From the article:
“DOST Secretary Fortunato de la Peña said the new kit will be a cell-based immunoassay for serologic testing…
The DOST-PCHRD-funded project, “Development of a Cell-Based Immunoassay for Coronavirus Disease 2019 (Covid-19) Serologic Testing”, is led by Dr. Fresthel Monica Climacosa of the University of the Philippines-Manila, together with collaborators from the University of Toronto, Canada…
t would benefit communities, researchers, and clinicians determined to address local and global burdens of Covid-19, specifically in improving access to diagnostic tools for mass disease surveillance, de la Peña added.”
https://www.pna.gov.ph/articles/1167243
#SDG#GlobalGoals#SDG3#SDG3GoodHealthandWellbeing#SDG4#SDG4QualityEducation#SDG17#SDG17PartnershipfortheGoals#2022UPMSDG4#2022UPMSDG3#2022UPMSDG17
